Existing research suggests that VCP/p97 has a strong potential to be a new therapeutic target for ischemic-reperfusion injury and pressure overload-induced cardiac hypertrophy, although there remain some opposing views. The gene discussed is VCP; the disease is cardiac hypertrophy.